
Mallinckrodt, a pharmaceutical giant launched in St. Louis, to take over Endo in $6.7B deal
From wire and staff reports Mallinckrodt PLC, an Irish pharmaceutical company with a big footprint and long history in the St. Louis area, will buy U.S. drugmaker Endo in a cash-and-stock deal valued at $6.7 billion. Endo shareholders will receive a total …